Drugs / DCB-WH1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00709514 | Dec 2008 → Apr 2011 | chronic ulcer of skin | Oneness Biotech Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DCB-WH1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00709514 ↗ |
| Route | Topical | “topically applied twice daily” NCT00709514 ↗ |